August 23 - 25, 2018 | San Francisco

Panel Workshop Details

Fri., Aug. 25, 8:45 AM - 11:45 AM PDT

Investing in the Future: From Biotech to High Tech*

In today's digital age, there isn't an area of society untouched by technology or biotechnology in some form or another. Improvements in medical equipment and research, rapid advances in technology, and the fast-tracking of breakthrough drugs make it a constantly changing, ever-evolving environment.

But a company that looks great on paper may not be a good fit for your portfolio. New competition, proposed mergers and acquisitions, changes in key management personnel, research and development breakthroughs, and quarterly earnings surprises-all intensify these sectors' notorious volatility. Some news items may be important signals, while others might simply be smoke. How do you separate rumor from the real deal? Join these tech and biotech experts as they reveal behind-the-scenes scoop on the companies that could be the next big winners.

*$109 per person if purchased by August 3; $139 after August 3

speaker photo
George Gilder

Founder and President

Gilder Publishing, LLC

speaker photo
John McCamant


Medical Technology Stock Letter

speaker photo
Cody Willard